Fitusiran - Wikipedia
Fitusiran is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in people aged twelve years of age and older with hemophilia A or hemophilia B, with or without factor …
Fitusiran (subcutaneous route) - Side effects & dosage
Aug 1, 2025 · Fitusiran injection is used to prevent or decrease the frequency of bleeding episodes in patients with hemophilia A or B with or without factor VIII or IX inhibitors.
QFITLIA® (fitusiran) | For US HCPs
Qfitlia™ (fitusiran) is an antithrombin (AT)-directed small interfering ribonucleic acid (siRNA) indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric …
Qfitlia approved as the first therapy in the US to treat hemophilia A ...
Mar 28, 2025 · The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce the frequency of …
Fitusiran Injection: MedlinePlus Drug Information
Fitusiran is used to prevent or reduce the frequency of bleeding episodes in people with certain types of hemophilia. Fitusiran is in a class of medications called antithrombin-directed small interfering RNA …
Qfitlia (fitusiran): Uses, Side Effects, Interactions, Pictures ... - WebMD
Apr 1, 2025 · Find patient medical information for Qfitlia (fitusiran) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
label - accessdata.fda.gov
QFITLIA is indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients aged 12 years and older with hemophilia A or B with or without...
Qfitlia (fitusiran) dosing, indications, interactions, adverse effects ...
Medscape - Hemophilia A and B dosing for Qfitlia (fitusiran), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.
Fitusiran prophylaxis in people with hemophilia A or B who switched ...
May 30, 2024 · Fitusiran, a subcutaneous investigational small interfering RNA therapeutic, targets antithrombin to rebalance hemostasis in people with hemophilia A or B (PwHA/B), irrespective of …
Fitusiran Uses, Side Effects & Warnings - Drugs.com
May 5, 2025 · What is fitusiran? Fitusiran is used in adults and children at least 12 years old with hemophilia A or B to help prevent bleeding episodes or make them occur less often.